MedPage Today on MSN
Oral Tebipenem Matched IV Antibiotic for Complicated UTIs in Phase III Trial
A TLANTA -- Oral tebipenem pivoxil (TBP-PI) was non-inferior to IV imipenem-cilastatin (IMI-CIL) for treating complicated ...
Q: I keep getting urinary tract infections (UTIs), and antibiotics don't seem to work like they used to. What's going on?
Data presented at IDWeek 2025 after study stopped early for efficacyPrimary endpoint met, demonstrating non-inferiority of ...
UTInil is a tablet specifically formulated to target urinary tract conditions—offering support in cases of bladder irritation ...
Genomic study reveals that zoonotic E. coli from contaminated poultry may cause nearly one in five UTIs, highlighting food ...
A 66-year-old man develops acute mania after antibiotic therapy for a urinary infection, highlighting a rare but serious ...
The study on urinary tract infections was based in Southern California, but researchers said the findings may apply to ...
GSK and Spero Therapeutics' oral cabapenem, tebipenem HBr, has become the first antibiotic in the class to show efficacy in a ...
IT’S been 18 months since Evan Francis last peed naturally, and shockingly she never will again. Her ordeal started with an ...
Each year, 10 million episodes are treated with antibiotics, but half of the time subsequent urine testing fails to confirm ...
Most children with neurogenic bladder (NGB) and diagnosed with febrile urinary tract infection (UTI) in the emergency ...
Under the terms of a deal that rescued the once-rejected tebipenem HBr, GSK will file for approval of the oral antibiotic. Back in 2022, after the FDA requested another phase 3 trial and denied ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback